 |
InFocus Archives
| CLINICAL NEWS FOR OUR PARTICIPATING HEALTH CARE PRACTITIONERS |
Best Practice: MedStar Health Offers Expert Care Recent Literature on: Asthma, Coronary Artery Disease, Congestive Heart Failure, Diabetes and Cancer Detect and Prevent CHD and Atherothrombotic Events Condition Centers Help Members Manage Chronic Diseases New and Emerging Technologies Medical Record Documentation Review for 2003 Postpartum Depression: Prevention Program Initiative Program Helps Ensure Great Beginnings 2003 MHCC HMO Report Cards Released Talking to Adolescent Patients About Health Issues
Best Practice: MedStar Health Offers Expert Care
The following is presented in an effort to highlight hospital “best practice” around the region. CareFirst BlueCross BlueShield (CareFirst) wants to share with you the innovative ways in which Maryland, Virginia and Washington, D.C. hospitals are improving quality of care while controlling the rising cost of health care. Look for additional “best practice” features in future issues of InFocus.
MedStar Health (MedStar) is a community based, nonprofit health care organization that includes seven major hospitals in CareFirst’s service area. MedStar offers an array of programs to meet the various needs of patients who benefit from the system. MedStar hospitals are comprised of teaching and community hospitals, some of which were named in U.S. News and World Report’s 2003 edition of America’s Best Hospitals.
| Hospital |
Features |
| Baltimore |
| Franklin Square Hospital Center |
Comprehensive cancer programs; state-of-the-art Women’s Pavilion for obstetrics and gynecologic care |
| Good Samaritan Hospital |
The Good Health Center, which provides fitness programs, educational seminars and screenings |
| Harbor Hospital |
Diabetes and Endocrine Center |
| Union Memorial Hospital |
Curtis National Hand Center, which offers specialized rehabilitation for patients with hand and upper extremity injuries/conditions |
| Washington, D.C. |
| Georgetown University Hospital |
Transplant Institute, which provides living donor liver transplants |
| National Rehabilitation Hospital |
Services designed to rehabilitate patients with disabling injuries and illnesses |
| Washington Hospital Center |
Only adult burn center in the Washington, D.C. area. |
|
Below are some of the innovative programs implemented by MedStar hospitals.
Medication Safety Program
In 1999, the National Academy of Sciences’ Institute of Medicine estimated that more Americans die from preventable medical errors, which include medication errors, than from workplace injuries. This costs the nation $29 billion in health care costs. As a result, MedStar developed a program to report errors and potential errors during the medication process. MedStar defines the steps of the medication
process as follows:
- Prescribing medication
- Dispensing medication
- Administering and monitoring medication
- Reporting effects and use of medication
|
MedStar’s staff can anonymously report errors or potential errors for which either they or a colleague is responsible. The anonymity of the program provides a safe environment for employees who report occurrences. Some changes made because of the reporting program include:
- Supplying more information on certain drugs to providers
- Using safer packaging
- Implementing a pilot program for electronic prescribing capabilities in physician practices and expanding protocol-driven medication orders in MedStar hospitals
Ensuring medication safety is an ongoing task and the responsibility is constant. “Medication safety is a journey, not a destination,” said MedStar’s Senior Vice President for Integrated Operations Steven Cohen.
Union Memorial’s Curtis National Hand Center
The Curtis National Hand Center (CNHC), based at Union Memorial Hospital, is staffed by certified hand surgeons and physical and occupational therapists who provide specialized rehabilitation for patients with hand or upper extremity injuries/ conditions.
Congenital Differences CNHC holds a free congenital clinic, available to adults and children, the second Thursday of every month (except for July, August and November 2004). Multiple surgeons “…provide …a consensus opinion on a recommended treatment plan, type of surgery (if needed), and advice on what age the surgery should be performed,” said Raymond A. Wittstadt, M.D., Hand Surgeon, Curtis National Hand Center. “This benefits the family by reducing the need for second opinions.”
After an evaluation with a multi-disciplinary team that includes hand surgeons, therapists and a pediatric geneticist, an individualized plan of care is determined for each patient and forwarded to the referring physician to implement as desired. Physical treatment options for these patients include therapy, prostheses and surgical intervention. Early surgical intervention might be necessary for cases with constriction band syndrome or syndactyly. Surgery is usually unnecessary when the patient is able to compensate for the deformity.
“Allowing a patient to live their life in a productive manner, never having to compromise what they want to pursue personally or professionally is one of the highest callings in our specialty,”said Thomas J. Graham, M.D., Chief of the Curtis National Hand Center.
If you know of a patient that would like to attend and would benefit from CNHC’s clinic, have the patient or a patient’s guardian call 410-235-5405 and CNHC will help them schedule an appointment at the clinic. Appointments are necessary because only four patients are evaluated at the clinic per month.
Curtis Work Rehabilitation Services
The Curtis Work Rehabilitation Services (CWRS) program offers assessment and rehabilitation for workers with all conditions, not just those involving the hand or upper extremity, that affect job performance. The program offers on-site workplace evaluations that identify risk factors for cumulative trauma and other work-related injuries. CWRS also offers on-site educational programs for employers and employees designed to establish/ improve ergonomic programs that help decrease workplace injuries.
Have your patients call 410-554-2170 for work rehabilitation services and 410-554-2976 for career assessments.
Good Samaritan’s Good Health Center
The Good Health Center, based at Good Samaritan Hospital, allows patients to take control of their health by providing continuous free health enhancement services, including:
- Blood Pressure Screenings
- Audiology Screenings
- Skin Cancer Screenings
Have patients call 410-532-GOOD for more information on these free services, as well as other, low-cost evaluations. The Center also offers individual and group instruction for Diabetes Self-Management. For more information on this program, call 410-532-4550.
Good Samaritan mails a newsletter, Good Health, to neighboring communities that features articles related to health care, a question and answer section and a pullout calendar with dates and times to take advantage of free and/ or low-cost classes.
Franklin Square Hospital’s Oncology Program
Franklin Square Hospital’s Oncology Program is recognized by the American College of Surgeons for overall excellence in oncology and was awarded accreditation at the teaching hospital level.
Franklin Square Hospital’s Center for Gynecologic Oncology and Center for the Diagnosis and Treatment of Digestive Cancers give patients access to a growing number of treatment options, including new medications and chemotherapy advances, through clinical trials.
Franklin Square is currently conducting more than 70 cancer-related clinical trials. These include studies for the National Surgical Adjuvant Breast and Bowel Project, the Gynecological Oncology Group, the Southwest Oncology Group, the National Cancer Institute’s Gynecologic Oncology Group and Institutional Review Board-approved pharmaceutical studies. Patients benefit from being able to enroll in the research protocols, as well as the knowledge providers gain from the studies.
The Harry and Jeanette Weinberg Cancer Center, Franklin Square Hospital’s upcoming addition to the Oncology Program, is scheduled to open in 2004. The new state-of-the-art facility will give providers opportunity for collaboration because a full-range of oncology services will be housed under the same roof.
Breast and Cervical Cancer Program
Women between the ages of 50-64 who are uninsured or under-insured and have a limited income are eligible to receive free mammograms, breast exams and Pap tests.
Baltimore City Residents should call—
- Harbor Hospital and Union Memorial Hospital at 410-350-2001
- Franklin Square Hospital at 410-887-3432
To find out where other free screenings are available, call 800-477-9774.
[top]
Recent Literature on: Asthma, Coronary Artery Disease, Congestive Heart Failure, Diabetes and Cancer
By T.A. Dadisman, MD, CareFirst Medical Director, Preventative Medicine and Health Promotion
This article is intended to call your attention to recent information you may have missed on issues concerning asthma, coronary artery disease, congestive heart failure, diabetes and cancer.
| What's Available |
Where to Find It |
| Asthma |
| “Patients with asthma have an underlying chronic inflammation of the airways characterized by activated mast cells, eosinophils and T-helper 2 lymphocytes. This results in increased responsiveness of the airways to such triggers as exercise, allergens and air pollutants. This chronic inflammation underlies the typical symptoms of asthma, which include intermittent wheezing, coughing, shortness of breath and chest tightness.” How Do Corticosteroids Work in Asthma? recognizes corticosteroids as the most effective treatment for asthma. The author points out that “…inhaled corticosteroids have become first-line treatment for children and adults with persistent symptoms. Corticosteroids suppress the chronic airway inflammation in patients with asthma, and the molecular mechanisms involved are now being elucidated.” |
Annals of Internal Medicine 2003; 139 (No. 5, Sep 2): 359-370 |
| Coronary Artery Disease |
| Depressive Symptoms and Health-Related Quality of Life stresses the importance of looking for and treating depression to improve patient health status. Depression is strongly associated with health status of patients with coronary artery disease and their symptoms, limitations, quality of life and overall health. Conversely, left ventricular ejection fraction, exercise capacity and ischemia are not associated with these patients’ health status. |
Journal of the American Medical Association 2003; 290 (No. 2, July 9): 215-221 |
| In the HOPE trial (New England Journal of Medicine 2000; 342:145-53), it was shown that ramipril, an ACE inhibitor, reduced cardiovascular event rates in patients with clinically evident cardiovascular disease (CVD). Subsequently, the LIFE study (American Journal of Hypertension 1997; 10:705-13) showed the same effect in patients with hypertension and left ventricular hypertrophy (LVH). Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease, a sub-study of the LIFE trial, shows reduced cardiovascular morbidity and mortality in hypertensive patients without clinically evident CVD treated with losartan, an angiotensin II AT1 receptor antagonist (i.e., angiotensin receptor blocker). |
Annals of Internal Medicine 2003; 139 (No. 3, Aug 5): 169-177 |
| Congestive Heart Failure (See also the 2nd reference under Diabetes) |
| The Epidemiology of ‘Asymptomatic’ Left Ventricular Systolic Dysfunction: Implications for Screening is a good article that informs readers of the prevalence of asymptomatic CHF and equivocal evidence for screening. See also another article that discusses the burden of CHF in the community (Journal of the American Medical Association 2003, 289 (No. 2, Jan 8) 194-202). |
Annals of Internal Medicine 2003; 138 (No. 11, June 3): 907-916 |
| Pharmacotherapy for Heart Failure in Patients with Renal Insufficiency is a useful article discussing the treatment in the 1/3 to 1/2 of CHF patients with renal insufficiency, including a treatment algorithm. |
Annals of Internal Medicine 2003; 138 (No. 11, June 3): 917-924
|
| Diabetes |
| Diabetes Prevalence among American Indians and Alaska Natives and the Overall Population- U.S., 1994 - 2002 recognizes that the prevalence of diabetes diagnoses is now 7.3 percent in adults aged 20 and older in the U.S., not including the estimated 30 percent who have diabetes and do not know it. The prevalence of known diabetes in the 65 and over population is 16.9 percent. |
Morbidity and Mortality Weekly Report 2003; 52 (No. 30, Aug 1): 702- 704 |
Heart Failure is an excellent article that addresses this frequently forgotten and often fatal complication of diabetes. Diabetic patients have a high frequency of heart failure and subsequent poor clinical prognosis because of the combination of diabetic cardiomyopathy, hypertension and ischemic heart disease. The author suggests that the prophylactic use of ACE inhibitors and beta- blockers be considered in high-risk diabetic patients to avoid the need to treat heart failure.
|
Diabetes Care 2003; 26 (No. 8, Aug): 2433-2441 |
| Management of Hypertension in Patients with Type 2 Diabetes includes discussions of the JNC VII classification, risk stratification and treatment recommendations for hypertension. Type 2 diabetes and hypertension are components of the cardiovascular dysmetabolic syndrome, a cluster of disorders that present an increased risk of morbidity and mortality. Therefore, hypertension in a patient with diabetes demands aggressive management. Angiotensin-converting enzyme inhibitors are the therapy of choice. Primary care physicians play the critical and challenging role of identifying high risk patients early, initiating effective treatment and following patients closely to facilitate adherence to pharmaceutical and lifestyle interventions. |
Advanced Studies in Medicine 2003; 3 (No. 6, June): 326-334 |
| Cancer |
| Controversies in Cancer Prevention and Screening points out that when a cancer screening test reduces mortality from a certain type of cancer, the test is usually considered beneficial. Because colorectal cancer screening reduces mortality, all adults 50 years and older should undergo screening. Current screening practices for breast cancer should not be changed, even though the usefulness of screening is still debated. Only women at high risk should consider a screening for ovarian cancer. For lung cancer, there is no evidence that screening reduces mortality. Decisions about screening remain complex among the elderly population due to morbidity and mortality from other diseases. |
Advanced Studies in Medicine 2003; 3 (No. 6, June): 316-325 |
| Evaluation of Abnormal Mammography Results and Palpable Breast Abnormalities is an excellent article about the work-up for breast abnormalities on mammography. The author concludes, “Women whose screening mammography results are interpreted as ‘suspicious abnormality’ or ‘highly suggestive of malignancy’ have a high risk for breast cancer and should undergo core-needle biopsy or needle localization with surgical biopsy. Women whose screening mammography results are interpreted as ‘need additional imaging evaluation’ have a moderate risk for breast cancer and should undergo diagnostic mammography or ultrasonography to decide whether a nonpalpable breast lesion should be biopsied. Women whose screening mammography results are interpreted as ‘probably benign finding’ have a low risk for breast cancer and can undergo follow-up mammography in 6 months. Either fine-needle aspiration biopsy or ultrasonography is recommended as the first diagnostic test of a palpable breast abnormality to distinguish simple cysts from solid masses. Fine-needle aspiration biopsy also allows characterization of a solid mass. Diagnostic mammography does not help determine whether a palpable breast mass should be biopsied and should not affect the decision to perform a biopsy.” |
Annals of Internal Medicine 2003; 139 (No. 4, Aug 19): 274-284 |
| Other Topics of Interest |
| The Quality of Health Care Delivered to Adults in the United States suggests that “…participants received 54.9 percent (95 percent confidence interval, 54.3 to 55.5) of recommended care. We found little difference among the proportion of recommended preventive care provided (54.9 percent), the proportion of recommended acute care provided (53.5 percent), and the proportion of recommended care provided for chronic conditions (56.1 percent).” The author also recognizes, “The deficits we have identified in adherence to recommended processes for basic care pose serious threats to the health of the American public. Strategies to reduce these deficits in care are warranted.” |
New England Journal of Medicine 2003; 348 (No. 26, June 26): 2635- 2645 |
| Awareness about Depression identifies depression as the third most common reason for consultation in primary care. The enhanced management of depression in primary care is central to the World Health Organization strategy for mental health. “A nationally representative household survey of the 48 contiguous United States conducted in 2001-2002 found that the lifetime prevalence of major depression is 16.2 percent, and the 12-month prevalence (i.e., meeting criteria for major depression in the preceding year) is 6.6 percent among U.S. adults, usually associated with substantial symptom severity and role impairment. Survey questions regarding treatment indicated that even though 57 percent of the respondents with 12-month major depressive disorder had received some treatment in the preceding year, less than 25 percent of those respondents had received treatment meeting criteria for being at least minimally adequate. Depression is a leading cause of disability worldwide.” Despite the frequency of presentation and the availability of effective interventions, the diagnosis and treatment of depression by non-specialist practitioners often do not follow current guidelines, potentially compromising patient outcome. |
Journal of the American Medical Association 2003; 289 (No. 23, June 18): 3145-3151 |
|
[top]
Detect and Prevent CHD and Atherothrombotic Events
By David H. Madoff, M.D., Ph.D., Chief, Division of Endocrinology and Metabolism, The Good Samaritan Hospital of MD, Inc., Assistant Professor of Medicine, The Johns Hopkins University of Medicine
About 2.2 million myocardial infarctions occur each year in the United States— 25-30 percent of which are fatal. These catastrophic events are often the first indication of Coronary Heart Disease (CHD). Since a majority of patients will suffer from an atherothrombotic event (i.e., MI, stroke, PVD) in their lifetime, it is the physician’s responsibility to determine the likelihood of an event and prepare a comprehensive preventative regimen.
Detecting an Event Framingham Risk Assessment Tool
The Framingham Risk Assessment Tool determines the 10-year risk of an atherothrombotic event by considering—
- patient’s age
- LDL-cholesterol
- HDL-cholesterol
- blood pressure
- smoking behavior
If the 10-year risk is >20 percent, then the patient is considered to have a CDH risk equivalent. A CHD risk of 10-20 percent is classified as intermediate, while a CHD risk of <10 percent is considered relatively low.
According to the Framingham Risk Assessment Tool, if a patient has diabetes, a risk of an event >20 percent in 10 years or atherothrombotic disease in a non-coronary vascular bed, then he/ she is considered to have a CHD risk equivalent and should be treated as if he/ she has coronary artery disease (e.g., LDL cholesterol <100 mg/dL).
NCEP ATP III Risk Factors
For patients without a CHD risk equivalent, physicians can consider the likelihood of an event using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) risk factors, which summarize the distinguishing factors that help identify a patient at high risk for an atherothrombotic event1:
- age >45 for men or >55 for women
- family history of CHD (first degree relative)
- blood pressure >140/90 (i.e., hypertension)
- HDL-cholesterol <40 mg/dL
- smoking behavior
If your patient has <1 risk factor, then he/ she is at relatively low risk for an event.
A patient is considered to have the Metabolic Syndrome, which doubles cardiovascular risk, if he/ she has 3 or more of these risk factors—
- waist circumference >35 inches for women, or >40 inches for men (i.e., central obesity) and
- elevated triglycerides (>150 mg/dL) and
- HDL-cholesterol <40 mg/dL for men, or <50 mg/dL for women and
- blood pressure >130/ >85 mm Hg, or
- fasting plasma glucose >110 mg/dL
Prevention of CHD and Atherothrombotic Events Treating patients at high risk involves a comprehensive regimen that can include—
- diet
- weight loss
- exercise
- relaxation
- smoking cessation
- aspirin
- statins and other lipid-lowering drugs
- antihypertensive therapy (including ACE-inhibitors or ARBs)
- fish oil
- certain diabetes medications (if necessary)
Judicious use of an aggressive regimen in a cohort of patients with Type 2 diabetes mellitus over 7.8 years resulted in a 53 percent reduction in atherothrombotic events and 60 percent reductions in retinopathy, nephropathy and autonomic neuropathy3.
Aspirin therapy is indicated for all aspirin-tolerant patients with known CHD or a CHD risk equivalent >1.5 percent risk per 10 years; the optimal dose is 81 mg qD. If the 10-year risk of an atherothrombotic event is 0.7-1.4 percent according to the Framingham Risk Assessment Tool, then the risks and benefits of aspirin are about equal. Therefore, aspirin is not indicated for patients with a <0.6 percent risk, but the patient can take it if he/ she chooses to4.
Data supports statin therapy as the mainstay of lipid lowering in most patients with known CHD or CHD risk equivalent (i.e., LDL cholesterol goal <100 mg/dL), as well as many high risk primary prevention patients. Based upon the algorithm above, all aspirin-tolerant patients placed on a statin should also take aspirin. A recent meta-analysis of five pravastatin trials that included 14,617 patients demonstrated a reduction of atherothrombotic events because of the clearly additive interaction between pravastatin and aspirin.
Percent Reduction of Atherothrombotic Events from Placebo |
| |
Pravastatin Alone |
Aspirin Alone |
Prava +Aspirin |
| Fatal or Non-fatal MI |
17 percent |
9 percent |
39 percent |
| Ischemic Stroke |
7 percent |
11 percent |
37 percent |
A new product, Pravigard, approved by the FDA at the beginning of July, contains a combination of essential anti-atherogenic medications and may substantially improve patients’ adherence.
CareFirst Preferred Drug List
Pravigard and Pravachol are on CareFirst’s Preferred Drug List.
References
- Circulation (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, 106, 3143.
- Ridker, P.M. (2001). Circulation. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease, 103, 1813.
- Gæde, P.,Vedel P., Larsen N., Jensen G.V.H., Parving H.H., & Pedersen O. (2003). New England Journal of Medicine.Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes, 348, 383-393.
- Lauer, M.S. (2002) New England Journal of Medicine. Aspirin for primary prevention of coronary events, 346, 1468-1474.
[top]
Condition Centers Help Members Manage Chronic Diseases
CareFirst offers Disease Management programs for eligible members with asthma, cancer, diabetes and heart conditions. All programs are designed to reinforce the physician’s plan of care. Services range from quarterly educational mailings to case management with 24-hour telephone access to a support nurse. Providers can direct members to our Disease Management Condition Centers.
Our Asthma, Diabetes and Heart Health Centers offer plenty of information and tools to help members manage their conditions. Members can—
- Read self-care tips and the latest news to learn more about their conditions.
- Take our monthly poll.
- Use our tools to track key health measures, like BMI, cholesterol readings, Hemoglobin A1c readings and blood sugar readings. My Care First can store this information on a secure server for future reference.
- Find out about classes and support groups in the area.
Members can access condition centers via My Care First or they can key in the address of the appropriate condition center:
[top]
New and Emerging Technologies
CareFirst's Technology Assessment Committee, which includes CareFirst physicians, CareFirst nurses and consulting physicians outside of CareFirst, reviews new and developing technologies. The committee relies on current medical literature, local expert consultants and physicians to determine whether those technologies meet CareFirst's criteria for coverage. Coverage policies applicable to national Blue Cross Blue Shield accounts and Federal Employees benefits programs may differ from those at the local account level. The review criteria can be found in the Providers & Physicians section of www.carefirst.com by clicking on Medical Policies. The Technology Assessment Committee recently made the following determinations.
| New Technology |
Description |
CareFirst Determination |
| TENS units for relief of chronic pain |
Transcutaneous electrical stimulation to block pain impulse |
Several technology assessment organizations, such as the Cochrane Database and the Canadian Coordinating Office for Health Technology Assessment, have reviewed published evidence, filtering for placebo controlled studies, on TENS units. Based on the results, these organizations concluded that TENS units are no more effective than placebo for pain relief and recommended against their use.
CareFirst considers TENS units for relief of chronic pain experimental/ investigational, based on the results of the controlled studies.
|
Co-polymer injection of the lower esophagus for gastroesophageal
reflux disease (Enteryx® system) |
This technique is supposed to narrow the gastroesophageal opening to reduce reflux |
Such an intervention is not considered medically necessary because the FDA labeled the injection for use in patients that are already responsive to treatment with medication.
CareFirst considers this injection experimental/ investigational based on lack of outcomes data.
|
| Cryoablation for renal cell carcinoma |
Proposed as a less invasive alternative to surgical resection in cases of early disease with relatively small tumor size |
Early indications imply that cryoablation is comparable in safety to laparoscopic excision. However, based on the evidence to date, it has not been determined whether survival rates are comparable as well. Patients may be eligible for clinical trial benefits if participating in approved clinical trials of this treatment.
CareFirst considers cryoblation for renal cell carcinoma experimental/ investigational, pending the report of 5-year survival data.
|
| Intradiscal electrothermal therapy/ annuloplasty for discogenic low back pain (IDET/ IDEA procedure) |
A thermal catheter is inserted into the intervertebral disc. When heated, the annulus shrinks, stabilizing the disc. |
May be considered medically necessary for patients with discogenic low back pain who have tried and failed at more conservative therapies, have undergone a program of spinal physical therapy without success, and would otherwise be considered a candidate for spinal fusion. This conclusion is based on a review of the most current peer-reviewed literature, including controlled clinical trials.
Intradiscal electrothermal therapy/ annuloplasty is considered medically necessary in carefully selected patients with chronic, refractory discogenic low back pain who meet all of the following criteria:
- The patient must have chronic, unremitting, low back pain for at least six months;
- The patient must have at least 50 percent of their disc height without the presence of osteophytes;
- The patient must have a negative neurological exam and be negative for radicular signs;
- The patient must have undergone a specialized program of physical therapy of at least 12 sessions, and have undergone a trial of epidural injections without success;
- The patient must have had a discogram that shows an intact disc without excessive tearing or degeneration.
Intradiscal electrothermal therapy/ annuloplasty is considered not medically necessary for all other conditions.
Please note that this coverage policy applies to local individual and group accounts only. National Blue Cross Blue Shield accounts administered by CareFirst may differ.
|
|
[top]
Medical Record Documentation Review for 2003
CareFirst BlueChoice annually assesses a random sample of primary care practitioners’ (PCP) medical records. This year, CareFirst BlueChoice found there are opportunities for improvement in medical record documentation. Quality Improvement (QI) nurses evaluated a sample of records for the adolescent care and adult hypertension HEDIS measures.
The following table shows there are opportunities to improve documentation for each of the elements related to health counseling for adolescents turning 13. Our 2005 performance goal is to improve documentation by 10 percentage points.
Health Counseling for Adolescents Who Turned 13 in 2003 |
Medical records were assessed for documentation of health counseling for: |
Percent of sample with appropriate documentation |
| Smoking |
25.7% (47/183) |
| Alcohol |
20.2% (37/183) |
| Drugs |
23.5% (43/183) |
| Sexual behavior |
25.1% (46/183) |
| All elements |
19.1% (35/183) |
The following table shows there is an opportunity to improve the documentation of health counseling (e.g., counseling for diet and exercise) for patients with hypertension. Our 2005 performance goal is to improve health counseling documentation by 10 percentage points.
Documentation of Elements Related to Controlling Hypertension |
Medical records were assessed of these elements related to hypertension control: |
Percent of sample with appropriate documentation |
| HBP on problem list |
75.2% (215/286) |
| Patient had a follow-up visit |
91.7% (263/286) |
| Evidence of medication review |
87.1% (249/286) |
| Evidence of health counseling |
40.2% (115/286) |
| Instructions for follow-up visit within specific timeframe |
64.7% (185/286) |
Providers should remember—
- That 12-13 year-old adolescents are generally old enough to receive health counseling for each of the elements.
- That adolescents may not feel comfortable discussing some health issues with a parent present.
- To always document counseling sessions.
- To take the opportunity to provide health counseling during visits for physicals or illnesses.
- That some companies’ medical record forms do not have enough space for the documentation of health counseling. To obtain our forms with sufficient space for documentation, call 410-528-7997 or 800-323-4472.
[top]
Postpartum Depression: Prevention Program Initiative
As many as 12.5 percent of new mothers suffer from postpartum depression, which can negatively impact the well-being of growing families. CareFirst BlueChoice and Magellan Behavioral Health (Magellan) worked together to develop the Prevention Program Initiative to treat CareFirst BlueChoice members with postpartum depression.
CareFirst BlueChoice members who deliver healthy babies receive information packets that contain the Edinburgh Postpartum Scale questionnaire, a screening tool for postpartum depression.
During 2002, information packets were mailed to 1,190 CareFirst BlueChoice members. Of these members, 12 percent completed the Edinburgh Postpartum Scale questionnaire and returned it to Magellan for scoring and follow-up. Nearly 20 percent of these responses indicated the possibility of postpartum depression and 43 percent of these members accepted a referral to a behavioral health specialist for a more formal evaluation.
Because early detection, diagnosis and treatment of postpartum depression can significantly reduce morbidity and may prevent mortality from this serious condition, CareFirst BlueChoice and Magellan will continue to implement the program through 2004. CareFirst BlueChoice providers can help make the Prevention Program Initiative successful by encouraging new mothers to complete and return the Edinburgh Postpartum Scale questionnaire and get treatment, if appropriate. If you have questions or supportive information, contact the Magellan Postpartum Depression Preventive Health Workgroup at 410-423-6702 or Mid-AtlanticSCPreventiveHealth@Magellanhealth.com.
[top]
Program Helps Ensure Great Beginnings
CareFirst and CareFirst BlueChoice designed Great Beginnings to supplement the prenatal care and education pregnant members receive from their doctors. The program screens members for high-risk characteristics and monitors their pregnancy to make sure they receive coordinated care. This prenatal care program helps members deliver healthier babies and avoid expensive emergency room admissions. When a member enrolls in Great Beginnings, a case manager contacts her to review her medical history and identify any other conditions that may affect her pregnancy.
Case Managers
Case Managers contact enrolled members each trimester to screen and assess pregnancy risk. Case Managers also work with physicians to coordinate an effective treatment plan based on the member’s individual needs. Members receive valuable information related to pregnancy and the baby’s development and learn about community resources, like available support groups during pregnancy and immediately after the birth. Case managers also help locate a nearby pediatrician to care for the new baby.
Goals
CareFirst and CareFirst BlueChoice hope this program:
- Promotes informed decision making and appropriate utilization of medical services.
- Reduces the number of days in the hospital/ neonatal intensive care unit, preserves pregnancy and decreases fetal/ maternal morbidity.
Outcomes
Currently, over 5,495 members have participated in Great Beginnings. Total cost savings since its launch in May, 2000 is $44.2 million dollars. There has been a positive trend in the following outcomes:
- 44% increase in enrollment
- 10% increase in Prenatal Care being initiated in the 1st trimester
- 1.88% decrease in the incidence of Fetal Demise
- 0.7% decrease in the incidence of Maternal Mortality
- 0.5% decrease in the incidence of Neonatal Mortality
If you have a patient that would like to enroll in the Great Beginnings prenatal care program, or to find out more about our program, providers and members can call 888-264-8648. A case manager will contact the member within two weeks of enrollment for an initial assessment.
[top]
2003 MHCC HMO Report Cards Released
The Maryland Health Care Commission (MHCC) recently released its annual guide for consumers on the performance of eight Maryland Health Maintenance Organizations (HMOs). The MHCC report card rates each of the Maryland HMOs on:
- Frequency members obtain preventive and wellness services
- Member satisfaction with the health care they receive
- How customers feel about their health plan
Report card results are based on the Consumer Assessment of Health Plans Survey (CAHPS) and clinical data from Health Plan Employer Data Information Set (HEDIS) audits. The report card, The 2003 Consumer Guide to Maryland HMOs & POS Plans, is published in its entirety by MHCC and is available online or by calling the Commission at 877-245-1762. CareFirst BlueChoice submitted data for the 2003 MHCC report card.
CareFirst BlueChoice’s performance was rated above average or average in 20 of the 30 MHCC categories – 16 of 22 clinical and 4 of 8 service categories. Above average performances were demonstrated in well-child visits for infants/ children, comprehensive diabetes care and prenatal care and check-ups for new mothers. The health plan was named “Star Performer”for better-than-average performance over several years in well-child visits for infants/ children and prenatal care and check-ups for new mothers. The major improvements are as follows:
- 67% - Adult diabetic members’ cholesterol control* (59% in 2002)
- 91% - Cholesterol screening rate for adult diabetics (83% in 2002)
- 94% - Prenatal care (89% in 2002)
- 83% - Postpartum care (77% in 2002)
- 34% - Adolescent immunizations, a combination of MMR, Hepatitis B and Varicella, (28% in 2002)
While acknowledging these improvements, CareFirst BlueChoice continues to evaluate and implement new processes to improve care and services for its members and is committed to exploring additional initiatives to improve member satisfaction.
The National Committee for Quality Assurance (NCQA) also publishes HEDIS results and compares many HMOs on a national and regional basis in The State of Health Care Quality 2003, available on NCQA's Web site.
* Control defined as an LDL-C of <130mg/dl.
[top]
Talking to Adolescent Patients About Health Issues
It is important to promote open discussions with adolescent patients about topics, such as drinking, drug use, smoking and sexual activity. The ability to anticipate patient’s needs and to be a safe, knowledgeable and available resource for guidance are vital. Early intervention is essential to prevent the development of serious problems among adolescents.
Communicate interest in the teenage patient by asking open-ended questions. Inquiring about school and peer issues make it clear that you are open to discussing difficult issues. Examples of questions include:
- How are things going in school or with your sports team?
- Do you have a lot of friends at school?
- Are there other things that you would like to talk about with me other than your sore throat?
Providing literature in your waiting room on issues, such as drugs, teenage sexuality, homosexuality, teenage pregnancy and STDs helps illustrate your knowledge of these subjects and that you are willing to discuss them. These brochures are available from organizations like the American Academy of Pediatrics.
Adolescent patients might be more willing to discuss uncomfortable issues if they know your office is a safe place to talk and that your goal is to have relationships with both the patient and the parent/ guardian. If the patient has concerns that he is reluctant to talk about with others present, suggest a confidential visit without a parent/ guardian. Some signs you should offer such a visit include:
- Something said confidentially to one of your staff members,
- Patient is anxious or avoids topics, or
- Uncharacteristic behavior for the particular patient.
Once a patient begins discussing his problems with you, careful listening is key. When rapport is established, you will have more success gaining additional information needed to clarify the scope/ nature of your patient’s difficulty. It is important to rule out whether the teen is in danger and requires immediate intervention, or if the teen is seeking information only, and immediate intervention is not necessary.
Depending on the issue, the patient may need help relating a problem to a parent/ guardian. Here are ways you can help:
- Suggest dialog the teen could have with his or her parents
- Offer to inform the parent with the teen’s consent
- Suggest that you or a member of your staff facilitate a meeting with the teen and the parents
Ask all your adolescent and adult patients the CAGE questions to
detect alcoholism:
- Have you ever felt that you ought to Cut down on your drinking?
- Do you get Annoyed at criticism of your drinking?
- Do you ever feel Guilty about your drinking?
- Do you ever take an Eye-opener to steady your nerves in the morning?
When a patient answers yes to 2 of these questions, it is a strong indication of alcoholism.
When a patient answers yes to 3 of these questions, it is a confirmation of alcoholism.
|
Another good way to detect alcoholism is to ask: “How do you use alcohol?”
- Patients who abuse alcohol will often ask, “What do you mean?”
- Patients who do not abuse alcohol often give straightforward answers.
|
| When alcoholism is detected, patients usually benefit from repeat visits scheduled to discuss possible reasons for excessive alcohol use. |
[top]
|
 |
 |
|